Samuel Mease, MD
Orthopaedic Surgery · Newark, DENPI 1346624681
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (38.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Arthrex at 38.6% of the total. Reporting peaked in 2022 at $7,857 and has fallen 86.9% since, to $1,030 in 2025.
Across 157 payments — averaging $103.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$6K
- Stryker$3K
- Eclipse Technology Solutions Inc.$2K
- Medtronic$1K
- Gotham Surgical Solutions & Devices, Inc.$1K
- Liberty Surgical Inc.$713
- plus $2K from 14 others
What the payments were for
- Consulting fees$6984%
- Grants$1,2728%
- Travel & lodging$3,23820%
- Food & beverage$6,27539%
- Education$4,80029%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 49 | $6,282 |
| Stryker | 53 | $2,796 |
| Eclipse Technology Solutions Inc. | 24 | $2,176 |
| Medtronic | 1 | $1,272 |
| Gotham Surgical Solutions & Devices, Inc. | 2 | $1,207 |
| Liberty Surgical Inc. | 7 | $713 |
| Medical Device Business Services, Inc. | 1 | $698 |
| Johnson & Johnson(2 entities) | 4 | $262 |
| Curvafix, Inc. | 2 | $224 |
| Zimmer Biomet | 2 | $173 |
| Davol Inc. | 2 | $131 |
| Globus Medical | 1 | $100 |
| Medline Industries LP | 1 | $90 |
| Smith+Nephew | 2 | $39 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| BD | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $20 |
| Bioventus LLC | 1 | $20 |
| KCI USA, Inc. | 1 | $19 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- T2 ALPHA$899
- T2$343
- GAMMA$265
- CurvaFix IM Implant$224
- AXSOS$152
- DISTAL EXTREMITIES IMPLANTS TRAUMA ANKLE FRACTURE$132
- COMPREHENSIVE$109
- VA-LCP$103
- Proximal Humerus Strut$100
How this compares
$16,282 in reported general payments places this provider in the 75th percentile of 70 orthopaedic surgery providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 41 | $172 |
| Ibuprofen | 26 | $152 |
| Gabapentin | 17 | $72 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Newark
- Jeremie AxeNewark$179K
- Kenneth LingenfelterNewark$67K
- Drew BradyNewark$64K
- Barry SharpeNewark$26K
- Adam SantoroNewark$9K
- Elliott LeitmanNewark$4K
- James CostanzoNewark$3K
- Matthew HandlingNewark$3K
- Christopher CasscellsNewark$1K
- Michael PushkarewiczNewark$342
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.